Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Dr. Charles AB
AB
Active
Org 5594388380
Rösundavägen 4
Day spa, sauna and steam bath activities · NACE 9623
Est. 2023
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 0
EBITDA margin
—
-32967% vs 2023
Equity ratio
4.7%
Financial strength
Net profit 2024
SEK -496K
-32967% vs 2023
EBITDA — year on year
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 0
—
EBITDA
SEK -496K
-32967%
Net profit
SEK -496K
-32967%
Total assets
SEK 532K
+2028%
Equity
SEK 25K
+6%
Employees
0
—
Company information
Legal name
Dr. Charles AB
Org number
5594388380
Legal form
Aktiebolag
NACE code
9623 · Day spa, sauna and steam bath activities
Founded
21 juni 2023
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Verksamheten ska driva försäljning utav egen producerade hudvårdsprodukter, injektioner samt hudbehandlingar.
Contact
Address
Rösundavägen 4
Email
malin.wahlstrom@victoriakliniken.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Day spa, sauna and steam bath activities
Companies in Nacka
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
SEK thousands
Item
2023
2024
Revenue
—
0
Staff expenses
—
—
EBITDA
−1
−496
Depreciation & amort.
—
−0
EBIT
−1
−496
Net financials
—
—
Profit before tax
−1
−496
Tax
—
−0
Net profit
−1
−496
Balance sheet
SEK thousands
Item
2023
2024
Total assets
25
532
Equity
24
25
Long-term debt
—
0
Short-term debt
2
507
Total debt
2
507
Financial ratios
5-year trend
EBITDA margin
-49600000.0%
This company
15.8%
Market median
-313924151% vs market
2023
2024
Equity ratio
4.7%
This company
38.2%
Market median
-88% vs market
2023
2024
Return on equity
-1984.0%
This company
18.4%
Market median
-10883% vs market
2023
2024
Net profit margin
-49600000.0%
This company
8.1%
Market median
-612345779% vs market
2023
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2023
2024
Debt / equity
20.28×
This company
0.62×
Market median
-3171% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-06-21 – 2023-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
CM
Charles Max Rickard Randquist
Board of Directors
2023
—
—
YS
Yvette Susann Randquist
Deputy Board Member
2023
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Deifiera Sundsvall AB
Company
100.0%
100.0%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Deifiera Sundsvall AB
Dr. Charles AB
(this company)
Board network connections
Board members of Dr. Charles AB also hold positions in
0
other companies.
Person
Role here
Other companies
Charles Max Rickard Randquist
Board of Directors
0 companies
Yvette Susann Randquist
Deputy Board Member
0 companies